The store will not work correctly when cookies are disabled.
N2-(2-(trifluoromethoxy)phenyl)-N4-(4-(trifluoromethyl)phenyl)pyrimidine-2,4-diamine
ID: ALA5189455
PubChem CID: 168282032
Max Phase: Preclinical
Molecular Formula: C18H12F6N4O
Molecular Weight: 414.31
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: FC(F)(F)Oc1ccccc1Nc1nccc(Nc2ccc(C(F)(F)F)cc2)n1
Standard InChI: InChI=1S/C18H12F6N4O/c19-17(20,21)11-5-7-12(8-6-11)26-15-9-10-25-16(28-15)27-13-3-1-2-4-14(13)29-18(22,23)24/h1-10H,(H2,25,26,27,28)
Standard InChI Key: OYAPRQWWNNYQOM-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
-1.8405 -2.4743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1259 -2.0621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4139 -2.4740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4139 -3.2993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1241 -3.7112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8405 -3.3030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1259 -1.2367 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.4112 -0.8241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4109 0.0011 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3019 0.4119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0168 -0.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0184 -0.8219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3065 -1.2384 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3019 1.2371 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0166 1.6498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0168 2.4752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7298 2.8860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4447 2.4732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4463 1.6520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7344 1.2354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5553 -2.0618 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.2700 -2.4743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9848 -2.0618 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-3.6827 -3.1891 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-2.8575 -3.1891 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.1595 2.8858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1595 3.7112 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.5722 2.1711 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.9848 2.8858 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
2 7 1 0
7 8 1 0
9 8 2 0
10 9 1 0
11 10 2 0
12 11 1 0
13 12 2 0
8 13 1 0
10 14 1 0
14 15 1 0
16 15 2 0
17 16 1 0
18 17 2 0
19 18 1 0
20 19 2 0
15 20 1 0
1 21 1 0
21 22 1 0
22 23 1 0
22 24 1 0
22 25 1 0
18 26 1 0
26 27 1 0
26 28 1 0
26 29 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 414.31 | Molecular Weight (Monoisotopic): 414.0915 | AlogP: 5.88 | #Rotatable Bonds: 5 |
Polar Surface Area: 59.07 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.40 | CX Basic pKa: 3.96 | CX LogP: 6.51 | CX LogD: 6.51 |
Aromatic Rings: 3 | Heavy Atoms: 29 | QED Weighted: 0.51 | Np Likeness Score: -1.47 |
References
1. De S, Aamna B, Sahu R, Parida S, Behera SK, Dan AK.. (2022) Seeking heterocyclic scaffolds as antivirals against dengue virus., 240 [PMID:35816877] [10.1016/j.ejmech.2022.114576] |